APTOSE BIOSCIENCES
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
APTOSE BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
1986-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.aptose.com
Total Employee:
11+
Status:
Active
Contact:
416-798-1200
Email Addresses:
[email protected]
Total Funding:
170.18 M USD
Technology used in webpage:
Euro ReCAPTCHA Amazon Frankfurt Region Thomson Reuters Multimedia Center
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Hanmi Pharmaceutical
Hanmi Pharmaceutical investment in Post-IPO Equity - Aptose Biosciences
Hanmi Pharmaceutical
Hanmi Pharmaceutical investment in Post-IPO Equity - Aptose Biosciences
Cowen Group
Cowen Group investment in Post-IPO Equity - Aptose Biosciences
Key Employee Changes
Official Site Inspections
http://www.aptose.com Semrush global rank: 4.96 M Semrush visits lastest month: 1.7 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Aptose Biosciences"
Aptose Biosciences Inc. (APTO)
Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.See details»
Company Information :: Aptose Biosciences Inc. (APTO)
Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular focus on hematologic …See details»
About :: Aptose Biosciences Inc. (APTO)
Aptose Biosciences is a clinical-stage biotechnology company focused on developing personalized therapies addressing unmet medical needs in oncology.See details»
Aptose Biosciences Inc. Announces Closing of $8 ... - Markets Insider
2 days ago · An electronic copy of the final prospectus relating to the Offering may be obtained on the SEC's website located at https://www.sec.gov and may also be obtained from …See details»
Aptose Biosciences Inc. (APTO) Company Profile & Overview
Nov 18, 2024 · Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the …See details»
Aptose Biosciences Inc. (APTO) - Stock Analysis
Get a real-time Aptose Biosciences Inc. (APTO) stock price quote with breaking news, financials, statistics, charts and more.See details»
Aptose Biosciences (APTO) Stock Price, News & Analysis
6 days ago · Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its …See details»
Aptose Biosciences Inc. (TSX: APS) - Stock Analysis
Nov 15, 2024 · Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. SAN DIEGO and TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- …See details»
Investor Relations :: Aptose Biosciences Inc. (APTO)
Nov 7, 2024 · Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular focus on hematologic malignancies. Aptose is advancing new …See details»
Aptose Biosciences Inc. (APTO) Stock Price Today - WSJ
View the latest Aptose Biosciences Inc. (APTO) stock price, news, historical charts, analyst ratings and financial information from WSJ.See details»
Aptose Biosciences Inc. Announces Closing of $8 Million
2 days ago · Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial …See details»
Aptose Biosciences Inc. (APTO) - Yahoo Finance Canada
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United …See details»
Aptose Biosciences Inc. (APTO) - Yahoo Finance
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United …See details»
Aptose Biosciences Inc. Announces Closing of $8 Million Public …
2 days ago · Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial …See details»
Aptose Biosciences - Crunchbase Company Profile & Funding
View contacts for Aptose Biosciences to access new leads and connect with decision-makers. Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and …See details»
APTO Stock Price Quote | Morningstar
Nov 19, 2024 · See the latest Aptose Biosciences Inc stock price (APTO:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Aptose Biosciences Inc. (APTO) - Yahoo Finance
Get the latest Aptose Biosciences Inc. (APTO) stock news and headlines to help you in your trading and investing decisions.See details»
Aptose Expands Senior Leadership Team
SAN DIEGO and TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated …See details»
Aptose Biosciences Closes US$8 Million Public Offering
3 days ago · Aptose Biosciences Inc. is a clinical-stage biotechnology company engaged in developing precision medicines addressing unmet medical needs in oncology, with an initial …See details»
Aptose Reports Results for the Third Quarter 2021
SAN DIEGO and TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company …See details»